Evidence map›Paper›PMID 32704567›Full record

ArticleEndocrinology, diabetes & metabolism2020

Prevalence of hypopituitarism and quality of life in survivors of post-traumatic brain injury.

Meriem Bensalah, Malcolm Donaldson, Malek Labassen, Lyes Cherfi, Mustapha Nebbal, El Mehdi Haffaf, Benaissa Abdennebi, Kamel Guenane, Zahra Kemali, Samia Ould Kablia

Open access · goldAbstract read
In one paragraph

Article in Endocrinology, diabetes & metabolism, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed, 2 pooled it
0.9field-weighted citation impact, top 25% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 2 syntheses or guidelines pooled it, 14 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Article
  4. The molecular basis of hypoprolactinaemia.Reviews in endocrine & metabolic disorders · 2024
    Review
  5. Traumatic brain injury and prolactin.Reviews in endocrine & metabolic disorders · 2024
    Review
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 3 institutions in 4 countries.

Meriem BensalahEndocrinology Unit Central Hospital of Army Algiers Algeria.ORCID https://orcid.org/0000-0002-5787-6076
Malcolm DonaldsonGlasgow University School of Medicine Glasgow UK.
Malek LabassenEndocrinology Unit Central Hospital of Army Algiers Algeria.
Lyes CherfiCritical Care Unit Central Hospital of Army Algiers Algeria.
Mustapha NebbalNeurosurgery Unit Central Hospital of Army Algiers Algeria.
El Mehdi HaffafNuclear Medicine Unit Central Hospital of Army Algiers Algeria.
Benaissa AbdennebiNeurosurgery Unit Salim Zemirli Hospital Algiers Algeria.
Kamel GuenaneCritical care Unit Salim Zemirli Hospital Algiers Algeria.
Zahra KemaliEndocrinology Unit Central Hospital of Army Algiers Algeria.
Samia Ould KabliaEndocrinology Unit Central Hospital of Army Algiers Algeria.
University of Algiers Benyoucef Benkhedda · DZ108 Military Central Hospital · VNUniversity of Glasgow · GB

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundHypopituitarism is a recognized sequela of traumatic brain injury (TBI) and may worsen the quality of life (QoL) in survivors.

aimsTo assess the prevalence of post-traumatic hypopituitarism (PTHP) and growth hormone deficiency (GHD), and determine their correlation with QoL.

methodsSurvivors of moderate to severe TBI were recruited from two Algerian centres. At 3 and 12 months, pituitary function was evaluated using insulin tolerance test (ITT), QoL by growth hormone deficiency in adults' questionnaire (QoL-AGHDA), and 36-item short-form (SF-36) health survey.

resultsOf 133 (M: 128; F: 5) patients aged 18-65 years, PTHP and GHD were present at 3 and 12 months in 59 (44.4%) and 23 (17.29%), 41/116 (35.3%) and 18 (15.5%). Thirteen patients with GHD at 3 months tested normally at 12 months, while 9 had become GHD at 12 months. At 3 and 12 months, peak cortisol was < 500 nmol/L) in 39 (29.3%) and 29 (25%) patients, but <300 nmol/L in only five and seven. Prevalence for gonadotrophin deficiency was 6.8/8.6%, hypo- and hyperprolactinaemia 6.8/3.8% and 5.2/8.6%, and thyrotrophin deficiency 1.5/0.9%. Mean scores for QoL-AGHDA were higher in patients with PTHP at 3 and 12 months: 7.07 vs 3.62 (

conclusionPrevalence of PTHP and GHD changes with time. AGHDA measures QoL in GHD more specifically than SF-36. Full pituitary evaluation and QoL-AGHDA 12 months after TBI are recommended.

Indexed as

growth hormone deficiencypost‐traumatic hypopituitarismQoL‐AGHDAquality of life

Identifiers

PMID32704567
PMCPMC7375098
OpenAlexW3033797738

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.